newsfilter
← Latest News
ACCESS Newswire·

IGC Pharma Reports 50% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial

POTOMAC, MD / ACCESS Newswire / September 22, 2025 / IGC Pharma, Inc. , a clinical-stage pharmaceutical company focused on therapies for Alzheimer's disease, today announced it has reached a key enrollment